Company profile
GlycoPath Inc
Our mission is to bring clinical glycomic assays to market.
- Industry
- Biotechnology Research
- Employees
- 2
- Headquarters
- Charleston, South Carolina
- Founded
- 2019
- LinkedIn followers
- 253
- Office locations
- 1
GlycoPath Inc company summary
GlycoPath Inc is a company in the Biotechnology Research industry, headquartered in Charleston, South Carolina, founded in 2019. On LinkedIn the company has around 2 employees and 253 followers. Its listed specialties include N-glycan imaging.
What technology does GlycoPath Inc use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About GlycoPath Inc
At GlycoPath, our mission is to generate new applications utilizing MALDI Mass Spectrometry Imaging to study changes in the glycosylation of various disease states. By generating streamlined methods with proven clinical impact, we hope to introduce accurate simplified assays to improve patient care and treatment. Glycopath is now a Bruker Company and part of Bruker Glycobiology Solutions. Stay tuned for updates. The proprietary GlycoTyper is designed to classify how the glycans, or sugar code on proteins, change during the development of cancer. For decades, the role of glycans and glycoproteins have been evaluated in cancer. Through extensive studies focused on elucidating the biological functions of glycosylation, researchers have been able to implicate alterations in these functions to tumor formation and metastasis. Although this has been studied for many years, the clinical relevance of these studies has been limited due to a lack of clinical assays. The GlycoTyper assay was developed to directly address the need for a more high-throughput method for protein-specific glycan analysis from biological samples. The glycan profiling technology captures diagnostic glycoproteins from blood using antibodies. These captured proteins then undergo direct glycan analysis using MALDI mass spectrometry.
Specialties
Where is GlycoPath Inc located?
GlycoPath Inc lists 1 location.
Compare companies similar to GlycoPath Inc
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
GlycoPath Inc glycopath.com | Biotechnology Research | 2 | 2019 | Charleston, South Carolina |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about GlycoPath Inc
What does GlycoPath Inc do?
At GlycoPath, our mission is to generate new applications utilizing MALDI Mass Spectrometry Imaging to study changes in the glycosylation of various disease states. By generating streamlined methods with proven clinical impact, we hope to introduce accurate simplified assays to improve patient care and treatment. Glycopath is now a Bruker Company and part of Bruker Glycobiology Solutions. Stay tuned for updates. The proprietary GlycoTyper is designed to classify how the glycans, or sugar code on proteins, change during the development of cancer. For decades, the role of glycans and glycoproteins have been evaluated in cancer. Through extensive studies focused on elucidating the biological functions of glycosylation, researchers have been able to implicate alterations in these functions to tumor formation and metastasis. Although this has been studied for many years, the clinical relevance of these studies has been limited due to a lack of clinical assays. The GlycoTyper assay was developed to directly address the need for a more high-throughput method for protein-specific glycan analysis from biological samples. The glycan profiling technology captures diagnostic glycoproteins from blood using antibodies. These captured proteins then undergo direct glycan analysis using MALDI mass spectrometry.
How many employees does GlycoPath Inc have?
GlycoPath Inc has around 2 employees on LinkedIn.
Where is GlycoPath Inc headquartered?
GlycoPath Inc is headquartered in Charleston, South Carolina.
When was GlycoPath Inc founded?
GlycoPath Inc was founded in 2019.
Build a lead list from companies like GlycoPath Inc
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.